Company Number: 14153787

Analysis Date: 2025-07-29 19:26 UTC

Financial Health Assessment for ACLEA LTD

---

1. Financial Health Score: B

Explanation:
ACLEA LTD demonstrates a solid financial footing for a micro entity in its early years of operation. The company shows a healthy increase in net current assets and net assets year-over-year, indicating improved liquidity and capital strength. However, the scale remains modest, consistent with a micro business, and the absence of liabilities is positive but may also reflect limited operational complexity. The score "B" reflects a sound financial condition with room for growth and potential risks typical for startups.

---

2. Key Vital Signs

Vital Sign	2023 (£)	2024 (£)	Interpretation
Current Assets	2,866	9,059	Healthy increase in short-term assets, likely cash or receivables, indicating improved liquidity.
Current Liabilities	2,730	0	Elimination of short-term debts suggests strong cash management or limited external borrowing.
Net Current Assets	136	9,059	Positive working capital "pulse" showing increased ability to cover short-term obligations.
Net Assets	136	9,059	Growth in equity—“strengthened heart muscle” of the business—reflecting retained earnings or capital injection.
Shareholders’ Funds	136	9,059	Equity backing the company, fully owned by a single shareholder, showing financial “immune system” stability.

---

3. Diagnosis

Symptoms Analysis:
The company is in the early stages (incorporated mid-2022) and classified as a micro entity, which typically entails limited operational scale and simplified reporting. The dramatic improvement in net current assets and net assets from £136 to £9,059 within one year signals a positive “recovery” or capital infusion phase. The zero current liabilities at the latest year-end indicate no immediate financial distress or overdraft reliance, akin to a patient with stable vital signs and no signs of acute stress.

The single director and sole shareholder structure suggests centralized control, which can be efficient but may also pose risks if governance oversight is minimal. The company operates in the packaging industry (SIC 82920), which can have variable cash flow cycles depending on client contracts and supply chain dynamics.

Potential Red Flags / Symptoms:

• Small scale limits diversification and resilience to shocks.
• No mention of profit or loss data; reliance on balance sheet alone may mask operational challenges.
• No liabilities could mean limited investment in growth or cautious expansion, which may slow scalability.

---

4. Recommendations

• Maintain Healthy Cash Flow: Regularly monitor liquidity to ensure the “circulatory system” (cash flow) remains robust, especially with growth ambitions.
• Develop Profit & Loss Transparency: If not already done, prepare management accounts showing profitability trends to diagnose deeper operational health.
• Plan for Growth Capital: Consider strategic reinvestment or external funding to build fixed assets or increase working capital, helping to strengthen the “muscle” of the business.
• Governance and Compliance: Ensure compliance with filing deadlines and maintain good corporate governance to avoid “infectious” regulatory issues.
• Risk Management: Identify and mitigate potential risks from supply chain or client concentration—diversify where possible to build resilience.
• Future Financial Planning: Create budgets and forecasts to anticipate future “health challenges” and opportunities, such as seasonal demand or market expansion.

---